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Cardiovascular diseases (CVD) represent the leading cause of maternal mortality and morbidity. Knowledge of CVD in women is
constantly evolving and data are emerging that female-specific risk factors as complications of pregnancy are conditions associated
with an increased risk for the long-term development of CVD. Echocardiography is a safe and effective imaging technique indicated
in symptomatic or asymptomatic pregnant womenwith congenital heart diseases who require closemonitoring of cardiac function.
Deformation imaging is an echocardiographic technique used to assessmyocardial function bymeasuring the actual deformation of
the myocardium through the cardiac cycle. Speckle-tracking echocardiography (STE) is a two-dimensional (2D) technique which
has been found to be more accurate than tissue Doppler to assess both left ventricular (LV) and right ventricular (RV) myocardial
function. The use of 2D STE however might present some technical issues due to the tomographic nature of the technique and the
motion in the three-dimensional space of the myocardial speckles. This has promoted the use of 3D STE to track the motion of
the speckles in the 3D space. This review will focus on the clinical value of the new echocardiographic techniques of deformation
imaging used to assess the maternal cardiovascular system in complicated pregnancies.
1. Epidemiology
Cardiovascular disease (CVD) remains the leading cause
of maternal mortality, and maternal cardiac diseases are a
major cause of nonobstetric morbidity, complicating 0.2 to
4% of pregnancies in industrialized countries. Older age
at the first pregnancy and the increasing prevalence of
hypertension, type II diabetes, and obesity represent themain
risk factors for cardiovascular complications in pregnancy
and postpartum [1]. Moreover, pregnant women with known
heart diseases requiremultidisciplinary obstetric andmedical
management to assess maternal and fetal risks; modern
ultrasonographic technologies are pivotal to allow these
patients to reach the childbearing age. In industrialized coun-
tries, congenital heart diseases account for 75–82% of CVD
in pregnancy, with shunt lesions predominating (20–65%),
whereas in nonindustrialized countries the major cause is
rheumatic valvular disease (56–89% of CVD in pregnancy).
Finally, cardiomyopathies are rare, but they may potentially
cause severe complications, and peripartum cardiomyopathy
is the most common of them [2].
2. Physiologic Cardiovascular Modification
during Pregnancy
During pregnancy, there are many physiological changes
due to the increased metabolic demand of the mother-fetus
couple, which requires an adequate uteroplacental circula-
tion. Impairment of these mechanisms of adaptation can
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cause a fetal or maternal disease, such as growth retardation
and preeclampsia, or unmask an underlying cardiac disease.
Pregnancy is associated with an increase in heart rate, which
starts in the first trimester, peaks in the third trimester
(15–25% increase over the baseline heart rate), and returns
to preconceptional values by 10 days postpartum. There is
also a hormonally mediated increase in blood volume, red
cells, and stroke volume (about 20–30%), although there are
many difficulties in calculating it [3]. These changes lead to
the increase in cardiac output by 30% in the first and second
trimester, reaching sometimes 45% in a singleton pregnancy
at 24 weeks. Whether or not cardiac output changes in the
third trimester is currently debated. However, we know that
it decreases rapidly in the first 2 weeks after the delivery,
until 24 weeks postpartum. The increase in cardiac output
seems to be due to increased stroke volume during early
gestation, to increased heart rate later on [2–4]. Immediately
after delivery, cardiac output further increases because of the
decompression of the inferior vena cava and autotransfusion
from the uterus.
Blood pressure typically decreases during normal ges-
tation and it is usually 10mmHg below baseline values in
the second trimester. There is no agreement about systolic
blood pressure change during pregnancy [2–8], but it appears
likely that both diastolic and mean arterial blood pressure
decrease from the early first trimester until 26–28 weeks and
then they rise again towards the end of the pregnancy [3, 7–
9]. Blood pressure changes are induced by a reduction in
systemic vascular resistance [10]. The uteroplacental circu-
lation and systemic vasodilatation contribute to the decline
in vascular resistance, which is the steady component of
ventricular afterload. Vascular resistance decreases in the
early first trimester, presents its nadir in the middle of
the second trimester, and returns close to prepregnancy
levels within two weeks after delivery [11]. Associated with
the decrease of vascular resistance, there is an increase in
global arterial compliance (approximately 30%), which is
the pulsatile component of ventricular afterload [2, 3]. The
abovementioned hemodynamic changes can be considered
the pathophysiological bases of cardiac remodeling during
pregnancy [2, 12]. In fact, a 15% increase of left atrial diameter
has been related to the increase in preload. It starts in the first
5 weeks and plateaus at 28–34 weeks’ gestation. Similarly, the
left ventricle (LV) increases its end-diastolic dimension by
7–12% beginning at 12 weeks and shows a plateau at 24–32
weeks [4]. Moreover, LV develops eccentric hypertrophy by
increasing left ventricular wall thickness (15–25%) and mass
(by 50%, mainly in the third trimester). These parameters of
left ventricular remodeling may remain above normal limits
until 6 months postpartum [10].
3. The Evaluation of Myocardial Function:
Strain Imaging
Echocardiography is the most frequently used imaging tech-
nique to assess cardiac function and hemodynamics in CVD.
Echocardiography allows a rapid assessment of systolic and
diastolic function of cardiac chambers, regional wall motion,
and valve anatomy and function [13]. Due to the safety of
ultrasounds, the wide availability of the technique, and its
portability and repeatability, echocardiography is very useful
to assess the cardiovascular system of pregnant women with
suspected or confirmed heart disease [2].
Deformation imaging is an echocardiographic technique
used to assess myocardial function by measuring the actual
change in length of the myocardium through the cardiac
cycle. Echocardiography can evaluate myocardial deforma-
tion through two methods: the first, tissue velocity imaging
(TDI), is a Doppler based method, whereas the second,
speckle-tracking echocardiography (STE), is based on the
analysis of conventional two-dimensional grayscale images.
Strain and strain rate, indices of myocardial deformation,
can be obtained with both TDI and STE. Using color TDI,
the SR is calculated as the velocity between 2 points along
the myocardial wall (velocity gradient) normalized for the
distance between the 2 points. TDI SR data can be integrated
over time to obtain strain that is the most frequently used
measure ofmyocardial deformation andmeasures the relative
lengthening or shortening of myocardial fibers compared to
baseline values. Since TDI is a Doppler based method and
velocity can only bemeasured along the direction of the ultra-
sound beam, only a limited number of strain components
can be measured by TDI. Usually, apical views are used to
calculate the longitudinal strain and the parasternal short-
axis views are used to calculate radial strain [14].
Conversely, STE is based on the detection on 2D images of
the motion of acoustic markers (called “speckles”) generated
by the interaction of ultrasounds with the myocardium. The
position of the speckles can be tracked during the cardiac
cycle by using specific software packages. The movement of
speckles can be used to measure strain and calculate SR. To
analyze the different components of myocardial deformation
(strain) with STE is necessary to acquire several views: 4-
chamber, 2-chamber, and apical long-axis views to compute
global longitudinal strain (GLS) and short-axis views for
circumferential and radial strains [15].
Strain and SR are used to estimate global and regional
myocardial function. The main advantages of these param-
eters are (i) the relative independency by loading conditions
as opposed to conventional chamber function parameters like
ejection fraction (EF) or stroke volume and (ii) the ability to
differentiate the active contraction of the myocardium from
passive motion resulting from the global heart translation or
from tethering by the surrounding myocardium [16].
Moreover, since it measures directlymyocardial function,
deformation imaging can detect subclinical myocardial dys-
function, when EF or other chamber function parameters are
still in the normal range because the heart has activated its
compensatory mechanisms. Since, during pregnancy, there is
a continuous variation of the loading conditions of the heart,
the use of STE can be particularly useful to study the changes
occurring in themyocardial function during either normal or
pathological pregnancy.
3.1. Strain: Basic Concepts. Strainmeasures the relative short-
ening/thickening of a myocardial segment during systole
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Figure 1: The image shows the three main components of myocar-
dial deformation: longitudinal, radial, and circumferential.
compared to its initial length/thickness in diastole and it
is a parameter used in echocardiography to describe the
myocardial deformation.
The linear strain (amount of deformation) can be defined
by the formula
𝜀 =
Δ𝐿
𝐿0
, (1)
where 𝜀 is strain, L0 is baseline length, and ΔL is change in
length.
Strain is unitless and it is expressed as a percentage.
Strain can assume negative or positive values, which reflect
shortening/thickening or lengthening/thinning, respectively
[17].
There are several components of myocardial deforma-
tion: longitudinal (measuring basal-apical shortening), radial
(measuring myocardial thickening), and circumferential
(measuring circular perimeter shortening) (Figures 1 and 2).
Since, during systole, the length of the LV shortens and
its circular parameter decreases, the systolic values will be
lower than diastolic ones. Accordingly, values for normal
longitudinal and circumferential strain will be negative. Con-
versely, during systole, the thickness of myocardial segments
increases. Therefore, the systolic values of radial strain will
be higher than diastolic ones and values for normal radial
strain will be positive [14]. SR describes the rate at which
the myocardial deformation occurs and it is expressed as
seconds−1 [18, 19]. Experimental studies have shown that the
SR is less dependent on LV load variations and better reflects
actual myocardial contractility than strain [20]. Nevertheless,
the SR signal is noisier and less reproducible than strain;
therefore, strain was the most frequently reported parameter
in clinical studies assessing myocardial function. The utility
of strain and SR has been documented in several clinical and
experimental studies which showed that they can provide
more information on pathophysiological mechanisms of
cardiac dysfunction compared to conventional parameters
describing cardiac chamber function (e.g., EF, stroke volume)
[21, 22].
3.2. Strain Obtained from Tissue Doppler Imaging. The first
echocardiographic method used to evaluate strain was TDI.
By this method, SR was derived from the velocity data using
the equation
SR =
(𝑉
1
− 𝑉
2
)
𝐿
, (2)
where 𝑉
1
is the velocity at point 1, 𝑉
2
is the velocity at point
2, and L is the distance between points 1 and 2, usually
set at 10mm. However, since it is a Doppler method, to
avoid underestimation of velocities, it is essential that the
ultrasound beam is aligned parallel to the direction of the
myocardial wall motion being studied [19].
The myocardial velocities can be measured using either
spectral pulsed tissue Doppler (TVI PW) or 2-dimensional
color-coded TDI image loop. However, myocardial velocities
obtained from the spectral pulsed TDI curves are higher than
those from 2D color-coded TDI images, because the former
measures peak velocities whereas the latter measures mean
velocities [23].
It is important to take into account the fact that mea-
surements performed by TDI may be influenced by both
blood flow and movement of the other adjacent structures.
Moreover, to minimize the effects of respiratory variations,
the patient should be asked to suspend his/her breathing for
several heartbeats and the operator should use respiratory
maneuvers during acquisition to improve the quality of
acquisitions [24].
3.3. Strain Obtained by Speckle-Tracking Echocardiography.
Speckle-tracking echocardiography is a relatively new ultra-
sound imaging technique based on the analysis of the spatial
dislocation of spots generated by the interaction between
the myocardial fibers and the ultrasound beam. These spots
are defined as “speckles” which are merged in functional
units (kernels) which have a unique pattern within the
myocardium. Therefore, each kernel can be individually
tracked during the cardiac cycle and its motion can be ana-
lyzed by dedicated software packages (Figure 3). By knowing
the position of the kernels at the beginning and at the end of
systole and the time between two frames (from frame rate),
the software can automatically calculate the deformation of
the myocardium (strain), the rate of the displacement, and
the rate of the deformation (SR) [25].
This method, different from TDI, is angle-independent,
provides accurate measures of myocardial deformation, and
guarantees good intraobserver and interobserver repro-
ducibility [26, 27]. GLS is a parameter of global LV function
obtained by averaging the peak values of systolic strain
obtained from the 17 segments of the LV [28]. Accordingly, to
obtain GLS, it is necessary to acquire and analyze three apical
views of the LV: 4-chamber, 2-chamber, and apical long axis.
A number of studies have demonstrated that GLS is an
accurate parameter to evaluate myocardial function [29, 30].
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Figure 2: The figure shows speckle-tracking analysis and the main components of myocardial deformation: radial (a), circumferential (b),
and longitudinal (c).
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Figure 3: The image shows a region of interest (kernel) at 𝑡
0
(a) and the relative change in its position at 𝑡
1
(b). Myocardial speckles in the
grayscale image are tracked frame-by-frame.
It has been reported to be more sensitive than EF in iden-
tifying subclinical left ventricular dysfunction in cardiomy-
opathies [31] and has shown an independent prognostic value
[32, 33]. Use of GLS to assess myocardial function has been
recommended in a variety of clinical scenarios [15, 27, 34].
The reference values for STE have been included in the
recent recommendations for cardiac chamber quantification
by echocardiography in adults [35].
The strain and SR values obtained with TVI and STE are
well correlated, even though the STE approach is more rapid
and reproducible and allows a more complete evaluation of
LV myocardial deformation due to its independence of the
ultrasound beam alignment [26].
3.3.1. 2D Speckle-Tracking Echocardiography Image Acquisi-
tion. To obtain images to be analyzed with the STE software
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Figure 4: Regions of interest (dotted lines) have been traced on apical long axis, 4- and 2-chamber views. Each region of interest is divided
into 6 segments for each view. The operator may accept/reject segments in case of suboptimal tracking of speckles.
package, it is recommended to optimize image quality by
using a grayscale second-harmonic 2D imaging technique
with careful adjustment of image contrast. The gain settings
should be optimized, the depth should be reduced, and the
focus should be in the middle of the left ventricle. Finally,
images should have adequate temporal resolution (50–90
frames per second) [19]. Lower temporal resolutions will
not allow a sufficient number of systolic frames to track the
motion of the kernels. Higher temporal resolutionwill impact
the spatial resolution of the images by reducing the number
of scan lines [36]. Moreover, it is essential to optimize the
LV border visualization. Care must be taken to avoid LV
foreshortening and image acquisition should be performed
during breath-hold to minimize respiratory interference. It
is essential that the electrocardiographic trace is stable to
avoid artefacts during the evaluation and at least three cardiac
cycles should be acquired for each loop [37]. Artefacts, such as
reverberation or shadowing, could affect strain computation
and provide wrong strain values, which might erroneously
suggest cardiac dysfunction.
3.3.2. 2D Speckle-Tracking Echocardiography Image Analysis.
The assessment of strain by 2D STE is a semiautomatic
method. The images recorded are processed using dedi-
cated software packages usually available on workstations
or included in the echo machine. The apical long-axis view
should be analyzed first to identify the end-systolic frame
looking at the movement of the aortic valve. A pulsed-wave
spectral Doppler envelope of LV outflowmay be helpful to set
the timing of cardiac events if the images of the aortic cusps
are suboptimal [17].
Endocardial border is identified by the software in all
apical views resulting in a manually adjustable region of
interest, which should exclude the bright pericardium [38].
The software package automatically divides each region
of interest into 6 segments for each view and the operator
may eventually accept/reject segments having the possibility
of modifying the shape and the thickness of the region of
interest in case of error of identification or incorrect tracking
(Figure 4).
After operator approval of tracking, a deformation
(strain) curve will be generated for each segment and the
software package reports the peak value of strain occurring
before aortic valve closure. GLS will be computed by averag-
ing the segmental values of peak strain.
To make interpretation of regional strain easier, the
software generates a “bullseye” map with red and blue color
coding, where the segments on the external ring represent
the basal LV segments, the middle ring segments represent
the midventricular segments, and the most internal ring
represents the apical segments [39] (Figure 5).
Several independent studies confirmed that a peakGLS in
the range of −20% can be expected in a healthy person [35].
A large study conducted on 247 healthy volunteers
showed that longitudinal strain was significantly more neg-
ative in women than in men. Therefore, separate lower limits
of normality for longitudinal strain should be used in men
(−16.9%) and in women (−18.5%) [40].
3.3.3. Three-Dimensional Speckle Tracking (3D STE). 2D STE
has become a popular and clinically useful technique, but
it is limited by the assumption that kernels move linearly
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Figure 5: Bullseye display of segmental peak-systolic longitudinal
strain. Global longitudinal strain is computed for each view.
along planes that coincide with the 2D echocardiographic
view. Conversely, myocardial motion is quite complex and
comprises rotation and displacement in the 3D space. Since
using 2D STE might cause the loss of some kernels in the
through-plane motion during the cardiac cycle, it has been
suggested that 3D STE may be a more suitable tool to track
the motion of the kernels in the 3D space [41].
To obtain myocardial deformation by 3D STE, we need
a pyramidal full-volume data set of the LV that can be
acquired using a matrix array transducer. To obtain a large
data set which contains the whole LVwith adequate temporal
resolution (30–36 volumes per second), we need a multibeat
acquisition to create a single volumetric data set by stitching
together subvolumes obtained from2 to 6 consecutive cardiac
cycles [42]. To avoid the stitching artefacts, acquisitions
should be done during suspended respiration and they are
feasible only in patients with regular cardiac rhythm [43].
Since with 3D STE it is possible to follow kernels in a volu-
metric space, the software can calculate simultaneously the
longitudinal, the radial, and the circumferential components
of myocardial deformation, plus a composite parameter (area
strain) which takes into account the simultaneous deforma-
tion in both longitudinal and circumferential direction atmid
myocardium [44]. Data relating to the normal values in adult
nonpregnant patients are known [45].
However, although it is theoretically appealing, at present,
3D STE still has several limitations that have not allowed for
its wide use in daily clinical practice (Figure 6).
4. Clinical Applications of Deformation
Imaging in Pathological Pregnancies
4.1. Preeclampsia. Preeclampsia is a hypertensive compli-
cation that affects 5–7% of pregnancies and is one of the
most common causes of maternal morbidity and mortality
[46]. In fact, it is considered a complex multiorgan disease
potentially involving the kidney, liver, and cardiovascular and
hematologic systems, as well as the brain. Autopsy data have
shown a tenfold prevalence of myocardial contraction band
necrosis in preeclamptic patients if compared with pregnant
women that died from other causes [47]. Some studies have
demonstrated persistent maternal cardiac impairment and
hemodynamic changes years after delivery [48, 49]. Valensise
et al. demonstrated that signs of left ventricular diastolic
dysfunction and persistent heart remodeling persist in non-
pregnant women before a second pregnancy with recurrent
preeclampsia. These findings could raise an issue concerning
preeclampsia as a cause or effect of heart remodeling [48–51].
The majority of published papers about echocardio-
graphic assessment of maternal heart in preeclamptic women
have used conventional parameters of cardiac function and
remodeling [50–55]. In preeclamptic patients, the use of
TDI and 2D STE demonstrated a reduction of both left
and right ventricular diastolic and systolic function, also in
preclinical stages of the disease, when cardiac output and
EF are still preserved. LV-mass, LV-mass index, and LV wall
thickness in preeclamptic women are higher than in healthy
controls, reflecting the increase in LV afterload. Myocardial
performance index (MPI), an index of reduced cardiac
systolic and diastolic function, also increased. An impairment
of right ventricular systolic function has been also described,
reflecting the increase of pulmonary resistance secondary to
LV diastolic dysfunction [56].
Moreover, several authors agree that longitudinal, radial,
and circumferential strains are impaired in preeclampsia and
may remain impaired also for months after the delivery, even
in patients with preserved cardiac output and EF [48, 49, 55,
57, 58]. An interesting consideration is that coexisting LV
hypertrophy and regional longitudinal systolic dysfunction
could reflect a regional subendocardial impairment, prob-
ably due to subendocardial ischemia and/or fibrosis seen
by Bauer et al. in preeclamptic women autopsies [47, 55].
Currently, new parameters based on 3D STE are emerging,
showing an increased ability to detect subclinical myocardial
impairment and early systolic and diastolic cardiac dysfunc-
tion. Myocardial dysfunction precedes chamber impairment
and 3D STE can provide an assessment of global and
regional LV function [59, 60]. Furthermore, some authors,
using 3D STE, demonstrated that early onset preeclamptic
patients presented worse cardiac remodeling than late onset
preeclamptic patients, underlining the clinical relevance of
detecting earlier and subtler cardiac dysfunction signs [58].
Other authors distinguish between preeclamptic and non-
proteinuric hypertensive women, showing less impairment of
longitudinal, circumferential, and radial strain in the latter
[59]. These findings could mean that hypertension may not
be the only cause of preeclamptic heart impairment, although
women with nonproteinuric hypertension presented a worse
cardiac function than healthy patients [57, 61].
4.2. Intrauterine Growth Restricted Pregnancies. Knowledge
of heart disease in women is constantly evolving and emerg-
ing data show that complications of pregnancy such as
preeclampsia and intrauterine growth restriction (IUGR) are
predictors for the development of heart disease later in life
[62]. Up to 10% of all pregnancies are affected by IUGR and
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Figure 6: Three-dimensional speckle-tracking echocardiography. The software package calculates simultaneously the longitudinal (a), the
circumferential (b), and the radial (c) components of myocardial deformation, plus a composite parameter (area strain) (d).
its definition is controversial. The main reasons of IUGR
are placental insufficiency and defective trophoblastic inva-
sion, currently evaluated by the estimated fetal weight and
umbilical artery Doppler flow velocity [63]. Fetal Doppler
evaluation is a useful method to predict fetal compromise
and permits distinguishing between severe IUGR and small
for gestational age (SGA) fetuses [64]. However, different
classifications are also reported in the literature and they
could generate confusion in the definition of both maternal
and fetal risk.
While maternal cardiac modifications occurring during
normal pregnancy are well known, in normotensive preg-
nancies with IUGR, there are contradictory lines of evidence
about maternal hemodynamics [3]. Some authors reported
reduced cardiac output and left ventricular compliance [65],
whereas others reported reduced maternal systolic cardiac
function and increased total vascular resistance, without
alterations of left diastolic function compared to physiolog-
ical pregnancies [66].
Moreover, IUGR patients, compared with preeclamp-
tic pregnancies, seem to present lower cardiac index, left
ventricular diastolic dysfunction, and higher total vascular
resistance index. Unlike preeclampsia, cardiac geometry and
intrinsic myocardial contractility were reported to be pre-
served, but a third of IUGR patients present reduced diastolic
reserve and an overt diastolic chamber dysfunction, despite
a normal EF [67]. This suggests that the cardiovascular
response is similar to that seen in preeclamptic patients,
though less severe. Lack of physiological adaptation to the
pregnancy, assimilating IUGR patients to a nonpregnant
hemodynamic condition, could explain the reason of high
resistance, low blood volume, and hypotensive condition,
which characterized IUGR patient’s condition [65]. The use
of cardiac indices in isolation lies at the basis of several
studies available in the literature, which make use of con-
ventional 2D and Doppler transthoracic echocardiography
[68]. A further improvement to the clinical presentation
in IUGR patients could be gathered by including in the
analysis the correlation between age and diastolic indices.
The introduction of TDI and 2D STE techniques for analysis
of myocardial deformation might allow an earlier diagnosis
and better grading of cardiac dysfunction [69]. While several
authors described the feasibility of STE in studying fetal
heart function and morphology, in particular, the segmental
and global systolic and diastolic velocities, strain, and SR
values, few studies described its application for the evaluation
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of IUGR patients [70]. Krause et al. investigated maternal
longitudinal mechanical dyssynchrony, a useful tool used
for the evaluation of LV function, finding that pregnancies
complicated by IUGR recorded significantly higher degrees
of inter- and intraventricular dyssynchrony than those of
normal controls [71].
5. Conclusion
Reduced maternal cardiac function in pregnancies that are
complicated by preeclamptic and intrauterine growth restric-
tion is the result of both reduced intrinsic myocardial con-
tractility and reduced diastolic filling. Myocardial dysfunc-
tion can be present even in the presence of a normal ejection
fraction, with significant decreases in radial, circumferential,
and longitudinal strain values.
The use of 2D and 3D STE techniques to evaluate ven-
tricularmechanicsmay help detect subclinical left ventricular
dysfunction in women affected by obstetrical pathologies
as preeclampsia and intrauterine growth restriction. Early
detection of left ventricular dysfunction with the institution
of appropriate treatment may reduce the risk of future CVD.
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